Bristol Myers to buy RayzeBio for $4.1 billion in targeted cancer therapy push

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/2/2026

1. DELL
2. MDT
3. SPY
4. PANW
5. AAPL
6. SPGI
7. USO
8. ENOV
9. GTLB
10. NIO

Go back to Bristol Myers to buy RayzeBio for $4.1 billion in targeted cancer therapy push
Bristol-Myers Squibb (NYSE: BMY) Delayed: 66.92 --0 (-0%)
Previous Close $66.92    52 Week High $77.12 
Open $66.92    52 Week Low $49.03 
Day High $66.92    P/E 43.45 
Day Low $66.92    EPS $1.54 
Volume 517       

(NASDAQ: RYZB) Delayed: 62.49 --0 (-0%)
Previous Close $62.49    52 Week High $ 
Open $0.22    52 Week Low $ 
Day High $62.49    P/E N/A 
Day Low $62.49    EPS $ 
Volume 707